FYB1

FYN binding protein 1

Basic information

Region (hg38): 5:39105252-39274528

Previous symbols: [ "FYB" ]

Links

ENSG00000082074NCBI:2533OMIM:602731HGNC:4036Uniprot:O15117AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • thrombocytopenia 3 (Strong), mode of inheritance: AR
  • thrombocytopenia 3 (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Thrombocytopenia 3ARHematologicIndividuals have been described with bleeding tendency, and awareness may allow early diagnosis, preventive measures, and early and aggressive treatment of bleeding episodesHematologic23650215; 25516138; 25876182

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FYB1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FYB1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
10
clinvar
3
clinvar
13
missense
56
clinvar
5
clinvar
4
clinvar
65
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
36
clinvar
36
Total 0 0 56 15 43

Variants in FYB1

This is a list of pathogenic ClinVar variants found in the FYB1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-39107251-T-A Benign (Jun 18, 2021)1182755
5-39107451-T-A not specified Uncertain significance (Feb 10, 2022)3097601
5-39107465-C-T not specified Uncertain significance (Jun 09, 2022)3097600
5-39107781-A-G Benign (Nov 11, 2018)1232537
5-39108207-A-G Benign (Jun 18, 2021)1230439
5-39108220-A-G Benign (Nov 11, 2018)1267008
5-39108243-C-T not specified Uncertain significance (Jun 07, 2023)2558758
5-39110312-A-T Benign (Jun 20, 2021)1256832
5-39110357-T-G Thrombocytopenia 3 Uncertain significance (Apr 09, 2018)1031985
5-39110379-G-A FYB1-related disorder Likely benign (May 23, 2019)3038884
5-39118886-C-T not specified Uncertain significance (Sep 16, 2021)3097598
5-39118901-C-A not specified Uncertain significance (Dec 19, 2022)3097597
5-39118918-G-A not specified Uncertain significance (Jul 12, 2023)2611427
5-39118925-T-A not specified Uncertain significance (Dec 18, 2023)3097596
5-39118981-G-A not specified Uncertain significance (Feb 16, 2023)2459274
5-39118985-T-C not specified Uncertain significance (Jul 26, 2022)3097595
5-39118987-A-G not specified Uncertain significance (May 08, 2024)3280252
5-39119120-T-G Benign (Nov 11, 2018)1278517
5-39119142-A-G Benign (Jun 21, 2021)1239268
5-39119459-T-C Benign (Nov 11, 2018)1255116
5-39119621-C-A Benign (Nov 11, 2018)1280849
5-39122338-C-A not specified Uncertain significance (Jul 14, 2023)2612024
5-39122399-A-G not specified Uncertain significance (Jul 27, 2022)3097594
5-39124256-A-G not specified Likely benign (May 04, 2022)2443135
5-39124406-C-T Benign (Nov 11, 2018)1180183

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FYB1protein_codingprotein_codingENST00000540520 19169293
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2380.7621246780181246960.0000722
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.4364374121.060.00002045465
Missense in Polyphen98102.950.951891407
Synonymous-0.9911721561.100.000008731585
Loss of Function4.37938.10.2360.00000181564

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002230.000223
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.0001170.000115
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as an adapter protein of the FYN and LCP2 signaling cascades in T-cells. Modulates the expression of interleukin-2 (IL-2). Involved in platelet activation. Prevents the degradation of SKAP1 and SKAP2. May play a role in linking T-cell signaling to remodeling of the actin cytoskeleton. {ECO:0000269|PubMed:10747096, ECO:0000269|PubMed:15849195, ECO:0000269|PubMed:16980616}.;
Disease
DISEASE: Thrombocytopenia 3 (THC3) [MIM:273900]: Thrombocytopenia is defined by a decrease in the number of platelets in circulating blood, resulting in the potential for increased bleeding and decreased ability for clotting. THC3 is an autosomal recessive form characterized by onset in infancy. {ECO:0000269|PubMed:25516138, ECO:0000269|PubMed:25876182}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Rap1 signaling pathway - Homo sapiens (human);T-Cell antigen Receptor (TCR) Signaling Pathway;Generation of second messenger molecules;TCR signaling;TCR;Immune System;Adaptive Immune System;Signal regulatory protein family interactions;Cell-Cell communication;TCR signaling in naïve CD4+ T cells (Consensus)

Recessive Scores

pRec
0.197

Intolerance Scores

loftool
rvis_EVS
-0.18
rvis_percentile_EVS
40.56

Haploinsufficiency Scores

pHI
0.0744
hipred
Y
hipred_score
0.655
ghis
0.506

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Mouse Genome Informatics

Gene name
Fyb
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; hematopoietic system phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
protein phosphorylation;NLS-bearing protein import into nucleus;immune response;signal transduction;integrin-mediated signaling pathway;biological_process;intracellular signal transduction;T cell receptor signaling pathway;protein localization to plasma membrane
Cellular component
nucleus;cytosol;plasma membrane;actin cytoskeleton;cell junction
Molecular function
signaling receptor binding;protein binding;lipid binding;protein-containing complex binding